tralokinumab-ldrm
Non-Formulary. Defer initiation to outpatient setting. Inpatients may use home supply.
Reviewed: June 2024
Tralokinumab (Adbry)
Non-Formulary. Defer initiation to outpatient setting. Inpatients may use home supply.
Reviewed: June 2024
Tralokinumab (Adbry)